ReviewCureus2026
Ebstein Anomaly: Imaging, Pathophysiology, and Therapeutics.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ebstein anomaly is a rare congenital malformation defined by failed delamination and apical displacement of the tricuspid valve, which produces an atrialized segment of the right ventricle and variable right ventricular dysfunction. Its clinical expression is wide, ranging from severe neonatal cyanosis and heart failure, which carry high perinatal mortality, to incidental detection in adulthood. Because anatomy and physiology vary widely among patients, imaging is central to diagnosis, risk stratification, and treatment planning. Transthoracic echocardiography remains the first-line study and establishes the diagnosis through apical leaflet displacement, leaflet tethering, and right atrial dilation; three-dimensional and transesophageal echocardiography refine the assessment of leaflet morphology and the atrialized right ventricle. Cardiac magnetic resonance imaging quantifies right ventricular and right atrial volumes, ejection fraction, regurgitant volume, and myocardial fibrosis, and increasingly informs the timing of surgery; computed tomography is a complement when magnetic resonance is contraindicated or extracardiac anatomy must be defined. Management is guided by current European and North American congenital heart disease guidelines and is matched to symptom burden and anatomy. Transplacental non-steroidal anti-inflammatory drugs may relieve the circular shunt in selected fetuses. Cone reconstruction has become the preferred surgical repair, with valve replacement reserved for valves deemed unsuitable. Catheter-based options, including device closure of interatrial communications, accessory-pathway ablation, and transcatheter tricuspid valve-in-valve implantation, address specific problems in higher-risk patients, although dedicated transcatheter replacement remains investigational in this population. Long-term care depends on serial imaging to detect residual regurgitation, progressive ventricular dysfunction, and arrhythmia. This review summarizes the anatomy, pathophysiology, multimodality imaging, and contemporary therapy of Ebstein anomaly, with emphasis on how imaging findings translate into clinical decisions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.